Provides online and in-person medical education and patient-management services, plus healthcare information, for healthcare professionals, patients, pharmaceutical companies and nonprofit organizations.
20-F for FY2025, filed Apr 3, 2026Zhongchao Shanghai, together with its subsidiaries, is a platform-based internet technology company offering services to patients with…View ↗
The PRC operating entities provide the healthcare information, education, and training services to the healthcare professionals under their…View ↗
In addition to their online presence, the PRC operating entities also hold onsite activities to provide healthcare information and…View ↗
The PRC operating entities’ customers are enterprises, NFP, and medical journals, primarily located in China. The PRC operating entities’…View ↗
Zhongxin Health’s customers are primarily pharmaceutical enterprises and NFPs including charity organizations, national public foundations…View ↗
Customers pay for medical courses in advance or after delivery. Fixed fees for patient-aid projects are collected in advance or after services; patented-drug sales are counted when customers accept the goods.
20-F for FY2025, filed Apr 3, 2026The Company designs and provides medical training and education courses in both online and offline formats to physicians and allied…View ↗
The Company is engaged by NFPs and pharmaceutical enterprises to assist in the operation of patient-aid projects with a purpose to…View ↗
The fees are fixed at the inception of the services and are collected either in advance or after the services are provided.View ↗
Starting from the year of 2022, the Company commenced sales of patented drugs to customers. The Company identified one performance…View ↗
20-F for FY2025, filed Apr 3, 2026
FY2025 revenue by product or service ↗$11.4M
20-F for FY2025, filed Apr 3, 2026
$11.4M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Medical training and education services
Sold outright
20-F for FY2025, filed Apr 3, 2026 |
60%
FY2022: 47%
|
Medical training and education services, FY2025
$6.9M Sources
|
Sold outright |
|
Patient management services in patient-aid projects
Recurring
20-F for FY2025, filed Apr 3, 2026 |
34%
FY2022: 44%
|
Patient management services in patient-aid projects, FY2025
$3.8M Sources
|
Recurring |
|
Sales of patented drugs
Sold outright
|
6.1%
FY2022: 8.6%
|
Sales of patented drugs, FY2025
$696.4K Sources
|
Sold outright |
The operating entities sell mainly to pharmaceutical companies, nonprofit organizations and medical journals in China, usually on a case-by-case or project basis; healthcare professionals and patients use the services.
20-F for FY2025, filed Apr 3, 2026The PRC operating entities’ customers are enterprises, NFP, and medical journals, primarily located in China. The PRC operating entities’…View ↗
The PRC operating entities’ enterprise customers are pharmaceutical enterprises, healthcare enterprises engaged in researches and develops…View ↗
The PRC operating entities’ NFP customers, most of whom are sponsored by pharmaceutical enterprises to produce training courses for…View ↗
The PRC operating entities maintain good relationship with their customers and some of them have long term relationship with us. The PRC…View ↗
Zhongxin Health’s customers are primarily pharmaceutical enterprises and NFPs including charity organizations, national public foundations…View ↗
Zhongxin Health provides patient management services through its Zhongxun IT system and WeChat mini program and its Zhongxin Health WeChat…View ↗
No. It lost $6.3M in FY2025.
20-F for FY2025, filed Apr 3, 2026
Shrinking. Revenue fell 30% in 4 years, from $16.3M in FY2021 to $11.4M in FY2025, about 9% a year.
Loading...